Agentic AI system may improve rare disease diagnosis
-
By
-
Matthew Solan
-
April 7, 2026
-
3 min
By
Matthew Solan
April 7, 2026
Phase III CUPID-C trial evaluates biologic therapy in patients with chronic spontaneous urticaria uncontrolled by antihistamines.
March 12, 2026